CTB-101

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCTB-101
Drug Alias NameCTB-101
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsPancreatic NeoplasmsMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanjing Bioheng Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Bioheng Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A